Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

TSH is usually the only test needed to check thyroid function in primary care.

Adult spiny mice recover better from heart attacks than common lab mice.

A 2-year-old boy with a rare brain malformation may have Gomez–López-Hernández syndrome.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Polarized microscopy helps identify hair irregularities in genetic disorders.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study aims to understand various diseases in older adults.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Nanozymes show promise for effective and safe cancer treatment.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.